Skip to content or view mobile version

Home | Mobile | Editorial | Mission | Privacy | About | Contact | Help | Security | Support

A network of individuals, independent and alternative media activists and organisations, offering grassroots, non-corporate, non-commercial coverage of important social and political issues.

Hidden Article

This posting has been hidden because it breaches the Indymedia UK (IMC UK) Editorial Guidelines.

IMC UK is an interactive site offering inclusive participation. All postings to the open publishing newswire are the responsibility of the individual authors and not of IMC UK. Although IMC UK volunteers attempt to ensure accuracy of the newswire, they take no responsibility legal or otherwise for the contents of the open publishing site. Mention of external web sites or services is for information purposes only and constitutes neither an endorsement nor a recommendation.

Exagen Diagnostics, Inc.(TM) Continues Growth Surge

Mr Roger K. Olsson | 20.09.2007 13:23 | Analysis | Other Press | Technology | London | World

Giuen Media



Thursday, September 20, 2007


ALBUQUERQUE, N.M., Sep. 20, 2007 (Business Wire) -- Preparing for growth, Exagen Diagnostics, Inc.(TM) today announced that it moved into larger office space in Austin and hired two directors in newly-created positions in advance of the commercial launch of its first genomic diagnostic test product, which will predict the likelihood of breast cancer metastisis in early-stage patients.

As Exagen continues developing genomic tests for a variety of diseases, the company named Barbara Preisel-Simmons, Ph.D. to serve as Senior Director of Clinical Affairs. As part of Exagen's Medical Affairs Department in Albuquerque, Dr. Preisel-Simmons will oversee the clinical studies conducted across the U.S. necessary to provide scientific and medical validation for the company's products. Dr. Preisel-Simmons brings 18 years of clinical investigation experience to Exagen, having previously held positions at Siemens Medical Solutions Diagnostics, Bayer HealthCare, Chiron Diagnostics, Abbott Laboratories and Baxter HealthCare.

'We are thrilled to have someone of Dr. Preisel-Simmons' caliber and experience joining our team,' said Luc Van Hove, M.D., Ph.D., Chief Medical Officer and VP of Quality, Regulatory, and Medical Affairs. 'Over the next two years, Exagen will be submitting at least six products for 510(k) and PMA review, and each one of those products will be validated by medical centers nationally. As our number of products grows, so does our need for experienced medical professionals to manage them.'

Exagen also added to its leadership team Human Resources Director Angela Marquez, SPHR who will manage the strategic operations of Human Resources and oversee the expansion of the company's employee base in Albuquerque and Austin. Ms. Marquez brings a diversity of experience from the public and private sector managing human resources most recently at Avila Retail Development and Management, LLC, and previously at MCI WorldCom and CVI Laser Corporation.

Exagen's team in Austin, which primarily directs the company's sales and marketing functions along with Customer Care and Regulatory Affairs, will nearly double and will now be housed in 8,500 square feet of office space at 4005 Banister Lane, near the intersection of Ben White and Lamar Boulevards. For the past two years, the company's Austin staff was located at 1250 Capitol of Texas Highway in a 4,500 square-foot space.

'Immediately, this is good news for Exagen and its employees who made this growth possible. Ultimately, this is great news for patients and physicians who will benefit from the genomic tests we produce,' said Chief Executive Officer James A. McClintic. 'Genomic diagnostic tests are the foundation of 'personalized medicine,' giving patients and doctors a new look at the genetic make-up of a particular disease in a particular patient, and the employees at Exagen are proud to be at the forefront of this emerging field in healthcare.'

About Exagen Diagnostics, Inc.

Exagen Diagnostics is a leader in discovering, developing, validating and delivering genomic marker test kits for use in the diagnosis and prognosis of diseases in the areas of cancer, gastroenterology, infectious disease and general medicine. Exagen designs diagnostic test kits so that they can be performed in any qualified clinical laboratory in the U.S. Because Exagen conducts its gene selection research on a supercomputer platform cross-referencing multiple genetic databases, called Coperna(TM), their test kits are develop faster and more affordably than traditional genetic research allows. Exagen's first test, eXagenBC, is currently pending 510(k) review at the FDA and assesses the risk of breast cancer recurrence. The company now has five more genetic test kits in development. www.exagen.com

Newstex ID: BW-0001-19710411


Delivered by Newstex LLC
via theFinancials.com

Mr Roger K. Olsson
- e-mail: rogerkolsson@yahoo.co.uk
- Homepage: http://groups.yahoo.com/group/economist-exquisite

Upcoming Coverage
View and post events
Upcoming Events UK
24th October, London: 2015 London Anarchist Bookfair
2nd - 8th November: Wrexham, Wales, UK & Everywhere: Week of Action Against the North Wales Prison & the Prison Industrial Complex. Cymraeg: Wythnos o Weithredu yn Erbyn Carchar Gogledd Cymru

Ongoing UK
Every Tuesday 6pm-8pm, Yorkshire: Demo/vigil at NSA/NRO Menwith Hill US Spy Base More info: CAAB.

Every Tuesday, UK & worldwide: Counter Terror Tuesdays. Call the US Embassy nearest to you to protest Obama's Terror Tuesdays. More info here

Every day, London: Vigil for Julian Assange outside Ecuadorian Embassy

Parliament Sq Protest: see topic page
Ongoing Global
Rossport, Ireland: see topic page
Israel-Palestine: Israel Indymedia | Palestine Indymedia
Oaxaca: Chiapas Indymedia
Regions
All Regions
Birmingham
Cambridge
Liverpool
London
Oxford
Sheffield
South Coast
Wales
World
Other Local IMCs
Bristol/South West
Nottingham
Scotland
Social Media
You can follow @ukindymedia on indy.im and Twitter. We are working on a Twitter policy. We do not use Facebook, and advise you not to either.
Support Us
We need help paying the bills for hosting this site, please consider supporting us financially.
Other Media Projects
Schnews
Dissident Island Radio
Corporate Watch
Media Lens
VisionOnTV
Earth First! Action Update
Earth First! Action Reports
Topics
All Topics
Afghanistan
Analysis
Animal Liberation
Anti-Nuclear
Anti-militarism
Anti-racism
Bio-technology
Climate Chaos
Culture
Ecology
Education
Energy Crisis
Fracking
Free Spaces
Gender
Globalisation
Health
History
Indymedia
Iraq
Migration
Ocean Defence
Other Press
Palestine
Policing
Public sector cuts
Repression
Social Struggles
Technology
Terror War
Workers' Movements
Zapatista
Major Reports
NATO 2014
G8 2013
Workfare
2011 Census Resistance
Occupy Everywhere
August Riots
Dale Farm
J30 Strike
Flotilla to Gaza
Mayday 2010
Tar Sands
G20 London Summit
University Occupations for Gaza
Guantanamo
Indymedia Server Seizure
COP15 Climate Summit 2009
Carmel Agrexco
G8 Japan 2008
SHAC
Stop Sequani
Stop RWB
Climate Camp 2008
Oaxaca Uprising
Rossport Solidarity
Smash EDO
SOCPA
Past Major Reports
Encrypted Page
You are viewing this page using an encrypted connection. If you bookmark this page or send its address in an email you might want to use the un-encrypted address of this page.
If you recieved a warning about an untrusted root certificate please install the CAcert root certificate, for more information see the security page.

Global IMC Network


www.indymedia.org

Projects
print
radio
satellite tv
video

Africa

Europe
antwerpen
armenia
athens
austria
barcelona
belarus
belgium
belgrade
brussels
bulgaria
calabria
croatia
cyprus
emilia-romagna
estrecho / madiaq
galiza
germany
grenoble
hungary
ireland
istanbul
italy
la plana
liege
liguria
lille
linksunten
lombardia
madrid
malta
marseille
nantes
napoli
netherlands
northern england
nottingham imc
paris/île-de-france
patras
piemonte
poland
portugal
roma
romania
russia
sardegna
scotland
sverige
switzerland
torun
toscana
ukraine
united kingdom
valencia

Latin America
argentina
bolivia
chiapas
chile
chile sur
cmi brasil
cmi sucre
colombia
ecuador
mexico
peru
puerto rico
qollasuyu
rosario
santiago
tijuana
uruguay
valparaiso
venezuela

Oceania
aotearoa
brisbane
burma
darwin
jakarta
manila
melbourne
perth
qc
sydney

South Asia
india


United States
arizona
arkansas
asheville
atlanta
Austin
binghamton
boston
buffalo
chicago
cleveland
colorado
columbus
dc
hawaii
houston
hudson mohawk
kansas city
la
madison
maine
miami
michigan
milwaukee
minneapolis/st. paul
new hampshire
new jersey
new mexico
new orleans
north carolina
north texas
nyc
oklahoma
philadelphia
pittsburgh
portland
richmond
rochester
rogue valley
saint louis
san diego
san francisco
san francisco bay area
santa barbara
santa cruz, ca
sarasota
seattle
tampa bay
united states
urbana-champaign
vermont
western mass
worcester

West Asia
Armenia
Beirut
Israel
Palestine

Topics
biotech

Process
fbi/legal updates
mailing lists
process & imc docs
tech